Market Trends– category –
-
Brazilian Deeptech Doroth Raises US$4.5 Million to Build Latin America’s First Microfluidic Chip Plant, Targeting 4 Million Annual Production
Latam Republic Brazil Overview Brazilian deeptech company Doroth has raised US$4.51 million to construct Latin America's first microfluidic chip manufacturing facility, aiming for an annual capacity of up to 4 million chips. This strateg... -
Wissen Research Forecasts In-Vitro Diagnostics Market to Reach $170.1 Billion by 2031, Driven by 7.7% CAGR
PR Newswire Global Overview This article provides an overview of a market research report published by Wissen Research on the global In-Vitro Diagnostics (IVD) market. The report projects the global IVD market to reach $170.1 billion by ... -
North American Personal Health Intelligence Market Pivots to AI-Powered, Wearable-Driven, Digital Biomarker Ecosystems
Morningstar USA Overview The North American Personal Health Intelligence Platforms market is undergoing a rapid transformation, shifting from basic health tracking to sophisticated, continuously updated, and personalized ecosystems drive... -
Dexcom Secures FDA Authorization for Stelo Glucose Biosensor System, First OTC CGM for Non-Diabetic and Non-Insulin Using Individuals
Devices@FDA (Dexcom) USA Overview Dexcom, Inc. has received FDA authorization for its 'Stelo Glucose Biosensor System,' marking it as the first over-the-counter (OTC) integrated continuous glucose monitor (iCGM) specifically for individu... -
Precedence Research Outlines Digital Biomarker Market Growth Driven by Wearables and AI Healthcare
Precedence Research Unknown Overview Precedence Research has published an overview of its market research report, indicating significant growth in the digital biomarker market, primarily fueled by the increasing adoption of wearable devi... -
Abbott Receives FDA Authorization for Libre Duo 10 Day: World’s First Dual Continuous Glucose and Ketone Monitoring System for Early DKA Warning
Medical Update Online (Abbott) USA Overview Abbott has secured FDA authorization for its Libre Duo 10 Day, the world's first dual continuous glucose and ketone monitoring (CGKM) system. This novel bio-wearable provides real-time glucose ... -
FDA Classifies Continuous Glucose Monitor Retrospective Data Analysis Software as Class I, 510(k) Exempt Medical Device
FDA.gov USA Overview The U.S. FDA has classified continuous glucose monitor retrospective data analysis software (Product Code PHV) as a Class I medical device, exempting it from 510(k) premarket notification. This software is intended t...
1